Paul E Holman, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1000 W Steuben St, Bingen, WA 98605 Phone: 509-493-2882 Fax: 509-493-2882 |
Back Works Unltd Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1000 W Steuben St, Bingen, WA 98605 Phone: 509-493-2882 Fax: 509-493-2882 |
Dr. Brian Robert Sweeny, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1000 W Steuben St Ste 1, Bingen, WA 98605 Phone: 509-493-0555 |
News Archive
AstraZeneca Canada announces the recently approved indication for IRESSA(R), a once-daily oral targeted therapy for the first-line treatment of patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK). In conjunction with this approval, AstraZeneca is also announcing the availability of a diagnostic test which can now determine a patient's EGFR mutation status, representing a new era in personalized lung cancer treatment in Canada.
On March 1, 2012, the American Academy of Otolaryngology-Head and Neck Surgery Foundation published a new Clinical Practice Guideline on Sudden Hearing Loss (SHL). This guideline is published as a supplement to Otolaryngology-Head and Neck Surgery.
Prime Healthcare Services Inc., a hospital chain that has come under fire for billing and patient privacy issues, is facing opposition over its potential acquisition of six California hospitals, including two medical centers in Los Angeles County. On Friday, hospital workers, union representatives and elected officials protested against Prime outside St. Vincent Medical Center near downtown Los Angeles, one of the six hospitals put up for sale this year by the Daughters of Charity Health System (Garland, 8/15).
Just because your mother has turned 85, you shouldn't assume you'll have to take over her financial matters. She may be just as good or better than you at making quick, sound, money-making decisions, according to researchers at Duke University.
The dementia drug rivastigmine may reduce the risk of falls in patients with Parkinson's disease by improving gait stability, findings from the phase II ReSponD trial show.
› Verified 4 days ago